Shares outstanding · 2016–2025
Anaptysbio shares outstanding
28.0M−8.1% · FY2025
Anaptysbio (ANAB) reported 28.0M in shares outstanding for fiscal 2025, −8.1% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 28.0M | −8.1% | Open → |
| FY20242024-12-31 | 30.5M | +14.6% | Open → |
| FY20232023-12-31 | 26.6M | −6.7% | Open → |
| FY20222022-12-31 | 28.5M | +3.1% | Open → |
| FY20212021-12-31 | 27.6M | +1.1% | Open → |
| FY20202020-12-31 | 27.4M | +0.4% | Open → |
| FY20192019-12-31 | 27.3M | +1.2% | Open → |
| FY20182018-12-31 | 26.9M | +13.2% | Open → |
| FY20172017-12-31 | 23.8M | +797.4% | Open → |
| FY20162016-12-31 | 2.7M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +30.0%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Anaptysbio shares outstanding |url=https://companiesranked.com/en/company/anaptysbio/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Anaptysbio shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/anaptysbio/shares-outstandingBibTeX
@misc{companiesranked-en-company-anaptysbio-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Anaptysbio shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/anaptysbio/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.